TY - JOUR
T1 - Evaluating the Use of ChatGPT to Accurately Simplify Patient-centered Information about Breast Cancer Prevention and Screening
AU - Haver, Hana L.
AU - Gupta, Anuj K.
AU - Ambinder, Emily B.
AU - Bahl, Manisha
AU - Oluyemi, Eniola T.
AU - Jeudy, Jean
AU - Yi, Paul H.
N1 - Publisher Copyright:
© RSNA, 2024.
PY - 2024/3
Y1 - 2024/3
N2 - Purpose: To evaluate the use of ChatGPT as a tool to simplify answers to common questions about breast cancer prevention and screening. Materials and Methods: In this retrospective, exploratory study, ChatGPT was requested to simplify responses to 25 questions about breast cancer to a sixth-grade reading level in March and August 2023. Simplified responses were evaluated for clinical appropriate-ness. All original and simplified responses were assessed for reading ease on the Flesch Reading Ease Index and for readability on five scales: Flesch-Kincaid Grade Level, Gunning Fog Index, Coleman-Liau Index, Automated Readability Index, and the Simple Measure of Gobbledygook (ie, SMOG) Index. Mean reading ease, readability, and word count were compared between original and simplified responses using paired t tests. McNemar test was used to compare the proportion of responses with adequate reading ease (score of 60 or greater) and readability (sixth-grade level). Results: ChatGPT improved mean reading ease (original responses, 46 vs simplified responses, 70; P <.001) and readability (original, grade 13 vs simplified, grade 8.9; P <.001) and decreased word count (original, 193 vs simplified, 173; P <.001). Ninety-two percent (23 of 25) of simplified responses were considered clinically appropriate. All 25 (100%) simplified responses met criteria for adequate reading ease, compared with only two of 25 original responses (P <.001). Two of the 25 simplified responses (8%) met criteria for adequate readability. Conclusion: ChatGPT simplified answers to common breast cancer screening and prevention questions by improving the readability by four grade levels, though the potential to produce incorrect information necessitates physician oversight when using this tool.
AB - Purpose: To evaluate the use of ChatGPT as a tool to simplify answers to common questions about breast cancer prevention and screening. Materials and Methods: In this retrospective, exploratory study, ChatGPT was requested to simplify responses to 25 questions about breast cancer to a sixth-grade reading level in March and August 2023. Simplified responses were evaluated for clinical appropriate-ness. All original and simplified responses were assessed for reading ease on the Flesch Reading Ease Index and for readability on five scales: Flesch-Kincaid Grade Level, Gunning Fog Index, Coleman-Liau Index, Automated Readability Index, and the Simple Measure of Gobbledygook (ie, SMOG) Index. Mean reading ease, readability, and word count were compared between original and simplified responses using paired t tests. McNemar test was used to compare the proportion of responses with adequate reading ease (score of 60 or greater) and readability (sixth-grade level). Results: ChatGPT improved mean reading ease (original responses, 46 vs simplified responses, 70; P <.001) and readability (original, grade 13 vs simplified, grade 8.9; P <.001) and decreased word count (original, 193 vs simplified, 173; P <.001). Ninety-two percent (23 of 25) of simplified responses were considered clinically appropriate. All 25 (100%) simplified responses met criteria for adequate reading ease, compared with only two of 25 original responses (P <.001). Two of the 25 simplified responses (8%) met criteria for adequate readability. Conclusion: ChatGPT simplified answers to common breast cancer screening and prevention questions by improving the readability by four grade levels, though the potential to produce incorrect information necessitates physician oversight when using this tool.
KW - Breast
KW - Education
KW - Health Policy and Practice
KW - Informatics
KW - Mammography
KW - Oncology
KW - Screening
KW - Technology Assessment
UR - http://www.scopus.com/inward/record.url?scp=85184344298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85184344298&partnerID=8YFLogxK
U2 - 10.1148/rycan.230086
DO - 10.1148/rycan.230086
M3 - Article
C2 - 38305716
AN - SCOPUS:85184344298
SN - 2638-616X
VL - 6
JO - Radiology: Imaging Cancer
JF - Radiology: Imaging Cancer
IS - 2
M1 - e230086
ER -